FDA Authorizes Expanded Access Program for ALS Treatment SPG302
This Week on NeurologyLive® — May 5, 2025
Gene-Targeted Therapies and Biomarkers Driving ALS Research Forward: Brian Lin, PhD
Hormonal and Neurological Complexity in Traumatic Brain Injury Recovery for Women